Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV.
Chawana TD, Walsh SR, Stranix-Chibanda L, Chirenje ZM, Yu C, Zhang L, Seaton KE, Heptinstall J, Zhang L, Paez CA, Gamble T, Karuna ST, Andrew P, Hanscom B, Sobieszczyk ME, Edupuganti S, Gay CL, Mannheimer SB, Hurt CB, Stephenson KE, Polakowski LL, Spiegel H, Yacovone M, Regenold S, Yen C, Baumblatt JA, Gama L, Barouch DH, Piwowar-Manning E, Koup RA, Tomaras GD, Hyrien O, Roxby AC, Huang Y; HVTN 127/HPTN 087, HVTN 130/HPTN 089 and HVTN 136/HPTN 092 Study Teams.
Chawana TD, et al. Among authors: stranix chibanda l.
BMC Immunol. 2025 Feb 19;26(1):8. doi: 10.1186/s12865-025-00687-7.
BMC Immunol. 2025.
PMID: 39966732
Free PMC article.
Clinical Trial.